On Treating Alcoholic Peripheral Neuropathy

Summary: Clinicians should consider the diagnosis of alcoholic polyneuropathy in patients who presently use alcohol excessively and patients who, while currently sober, have a history of such behavior.

In 2015, according to The National Institutes of Health (NIH), there were approximately 15 million alcoholics in the US–with estimates suggesting that up to 10 million of them suffered from the most common neurological complication associated with alcoholism, painful small fiber peripheral neuropathy.  As previously discussed, the toxic effects of alcohol on intestinal thiamine (vitamin B1) transporter molecules act to inhibit the absorption of dietary/water soluble thiamine. This leads to thiamine deficiency and contributes to alcoholic peripheral neuropathy.

The duration and quantity of alcohol consumption over the course of a patient’s lifetime are the factors most directly associated with the development of alcoholic peripheral neuropathy. Clinicians should take a detailed history of their patient’s alcoholic consumption–keeping in mind that many patients tend to underreport their use of alcohol.  Patients with painful polyneuropathy who currently drink alcohol to excess and reformed alcoholics–no matter how long the length of sobriety–should be considered for treatment with thiamine supplementation if the patient’s lifetime consumption of alcohol warrants it.

Clinically, supplementation with benfotiamine, a lipid soluble form of thiamine, has been shown to safely and rapidly reverse thiamine deficiency in alcoholics and is an excellent treatment choice for these patients.*


A request from the author:
Have any of your patients who have taken NeuRemedy experienced any benefits in addition to improvement in their neuropathic symptoms? If so, I would like to know. Please contact me at rhm123@gmail.com or call me at 561-549-9099.


Dr. Mann bust-shot

Dr. Richard H Mann, DABPS, ret
Chief Scientific Officer & Founder, Realm Labs

If you would like to speak with Dr. Mann about how to improve your outcomes in the treatment of polyneuropathy call 866-634-2745 or email Dr. Mann at realmlabs123@gmail.com

Dr. Mann is the developer of the  NeuRemedy®line of benfotiamine nutritional supplements. NeuRemedy is a safe, proven, and effective nutritional formulation dispensed by physicians to their patients suffering from numbness, tingling, burning and/or shooting pains in the feet and legs. These symptoms are commonly associated with diabetes, prediabetes, advanced age, chronic alcohol consumption, and chemotherapy. Thiamine (vitamin B1) deficiency often accompanies and intensifies these symptoms. The reversal of thiamine deficiency is an important therapeutic goal in the management of these patients.*

The key ingredient in NeuRemedy, benfotiamine, is the most highly bioactive oral form of thiamine available. It rapidly and safely reverses thiamine deficiency, improving the functioning of the nerves in the feet and legs. Each capsule of NeuRemedy contains 150 mg of benfotiamine in a proprietary formulation. Because of its impressive success rate and high safety profile, NeuRemedy was recently licensed in Canada as an important factor in supporting healthy nerve function in individuals with polyneuropathy.* NeuRemedy is the leader in the field with thousands of physicians and patients relying each day on its efficacy, purity, safety and rapid onset of action.*

For more information on NeuRemedy, in the USA, contact Realm Labs at 866-634-2745.
In Canada contact OHI at 855-561-4156.

Leave a Reply

Your email address will not be published. Required fields are marked *